corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 16869

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Tfelt-Hansen PC
Unpublished clinical trials with sumatriptan
The Lancet 2009 Oct 31; 374:(9700):1501 - 1502
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61906-1/fulltext


Abstract:

In 1991, the first triptan, sumatriptan, became available in Europe for the treatment of acute migraine attacks. In 1994-95, a randomised clinical trial (RCT) of sumatriptan 25 mg suppositories versus Cafergot (ergotamine 2 mg plus caffeine 200 mg) suppositories was done in France and Germany. I became aware of this RCT in 1998 when the main result was published on the homepage of the Swedish Medical Agency. I included the finding, that Cafergot resulted in headache relief (a decrease from moder …

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend